Jeffery S Nelson

Title: Jeffery S Nelson: Innovator in Oligonucleotide Synthesis

Introduction

Jeffery S Nelson is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of oligonucleotide synthesis, particularly through his innovative methods that enhance product yields and reduce reagent usage.

Latest Patents

One of his key patents is titled "Solid phase synthesis of oligonucleotide N3'-P5' phosphoramidates." This invention provides a method for synthesizing oligonucleotide N3'.fwdarw.P5' phosphoramidates using an amine-exchange reaction of phosphoramidites. In this method, a deprotected 3'-amino group of a solid phase supported oligonucleotide chain is exchanged for the amino portion of a 5'-phosphoramidite of an incoming monomer, which has a protected 3'-amino group. The resulting internucleotide phosphoramidite linkage is then oxidized to form a stable protected phosphoramidate linkage. This method greatly improves product yields and reduces reagent usage compared to currently available methods for synthesizing this class of compounds. Jeffery holds 1 patent.

Career Highlights

Jeffery S Nelson is associated with Lynx Therapeutics, Inc., where he applies his expertise in oligonucleotide synthesis. His work has been instrumental in advancing the methodologies used in this field.

Collaborations

Throughout his career, Jeffery has collaborated with notable colleagues, including Sergei M Gryaznov and Karen L Fearon. These collaborations have contributed to the development of innovative solutions in oligonucleotide synthesis.

Conclusion

Jeffery S Nelson's contributions to the field of oligonucleotide synthesis through his patented methods demonstrate his commitment to innovation and improvement in scientific research. His work continues to influence the industry positively.